Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer

D A Cameron, D R Camidge, J Oyee, M Hirsch

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences